The announcement was made at Arab Health 2025, where Sidra Medicine will showcase its global patient care initiatives, including flagship services like the Heart Center, gene therapy, and reproductive medicine, among others.
Prof Tawfeg Ben-Omran, division chief of Genetic and Genomic Medicine at Sidra Medicine, said: “In response to the overwhelming demand from neighbouring countries, the establishment of the Gene Therapy Center is a crucial step in meeting the needs of families seeking cutting-edge treatments for SMA and DMD. As a Qatari institution, our goal is to create a regional centre of excellence, where children from across the Arab world can access advanced therapies without the need to travel long distances, bringing world-class care closer to home.”
Learn More: Will Elevidys Receive Approval from the European Medicines Agency (EMA)?
